Cowen Inc’s Allergan plc AGN Stock Holding History

Cowen Inc’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-900	Closed	-$281K	–	376
2015 Q4	$281K	Hold	900	–	–	0.02%	237
2015 Q3	$245K	Hold	900	–	–	0.01%	202
2015 Q2	$27K	Buy	+900	New	+$268K	﹤0.01%	444

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Cowen Inc's AGN Position: Q4 2017 in Review

Cowen Inc sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 11,800 shares — an estimated $2.42M sold.

Cowen Inc first reported a position in AGN in Q2 2013 and held it in 14 quarters. The position peaked at $235M in Q1 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

Cowen Inc reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
Cowen Inc sold 11,800 Allergan plc shares in Q4 2017, an estimated $2.42M.
Cowen Inc first reported a position in Allergan plc in Q2 2013 and held it in 14 quarters.
Cowen Inc's Allergan plc position peaked at $235M in Q1 2016.
1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Cowen Inc's 13F filing for Q4 2017, filed 15 Feb 2018.